← Open Payments lookup

TRICIA CARVALHO: Open Payments

NPI 1043533508 · COLUMBIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,395 in 162 payments from 20 companies in 2025. Trend: 2023 $1,652 · 2024 $3,674 · 2025 $3,395

Food & beverage: $3,395
CompanyPaymentsAmount
Madrigal Pharmaceuticals14$572
Janssen Biotech, Inc.18$451
Takeda Pharmaceuticals U.S.A., Inc.21$415
PFIZER INC.30$398
ABBVIE INC.17$377
Salix Pharmaceuticals, a division of Bausch Health US, LLC16$283
GENZYME CORPORATION7$217
Ardelyx, Inc.15$195
Celltrion USA Inc.6$106
Lilly USA, LLC2$60

Products named: REZDIFFRA, TREMFYA, XIFAXAN, ENTYVIO, VELSIPITY, DUPIXENT, IBSRELA, XELJANZ.

Industry payments across MD — which companies pay providers there.